Literature DB >> 10616706

Familial Mediterranean fever in children: the expanded clinical profile.

H A Majeed1, M Rawashdeh, H el-Shanti, H Qubain, N Khuri-Bulos, H M Shahin.   

Abstract

The clinical picture of familial Mediterranean fever (FMF) has been appreciably expanded in the last 10 years. Over 8 years, we studied the expanded clinical profile of FMF in 476 children. Of these, 81% had abdominal pain, 41% chest pain, 42% arthritis, 12% severe myalgia, 12% skin manifestations, 4% scrotal swelling, 3% recurrent episodic fever, and one child (0.2%) developed recurrent hyperbilirubinaemia. Two (0.4%) children developed renal complications which were reversed by colchicine; however of 19 probands, 36 family members suffered from chronic renal failure. Our study indicates a familial predisposition to nephropathy in certain families with FMF. This study is the first to report the expanded clinical profile of FMF in a large group of Arab children, giving an opportunity to compare the findings with those in children with FMF in other ethnic groups, and to help in the study of genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616706     DOI: 10.1093/qjmed/92.6.309

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  22 in total

1.  Familial Mediterranean fever in Syrian children: phenotype-genotype correlation.

Authors:  Rami A Jarjour; Sumaya Al-Berrawi
Journal:  Rheumatol Int       Date:  2014-08-24       Impact factor: 2.631

2.  Familial Mediterranean fever protracted febrile myalgia in children: report of two cases.

Authors:  Vildan Ertekin; Mukadder Ayşe Selimoğlu; Handan Alp; Nebahat Yilmaz
Journal:  Rheumatol Int       Date:  2004-12-10       Impact factor: 2.631

3.  Acute renal failure in a patient with familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Selçuk Yüksel; Arzu Ensari; Mesiha Ekim; Fatoş Yalçinkaya
Journal:  Rheumatol Int       Date:  2006-09-02       Impact factor: 2.631

4.  Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.

Authors:  Rotem Tal; Rotem Semo Oz; Gil Amarilyo; Tal Eidlitz-Marcus; Ori Goldberg; Yoel Levinsky; Orit Peled; Liora Harel
Journal:  Rheumatol Int       Date:  2019-06-22       Impact factor: 2.631

5.  Isolated myositis as a sole presentation of familial Mediterranean fever.

Authors:  Kamal Akl; Mohammad O Rawashdeh
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

6.  Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey.

Authors:  Can Ozturk; Oya Halicioglu; Işil Coker; Nesrin Gulez; Sumer Sutçuoglu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2011-11-05       Impact factor: 2.980

7.  Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey.

Authors:  Elif Ozalkaya; Sevgi Mir; Betul Sozeri; Afig Berdeli; Fatma Mutlubas; Alphan Cura
Journal:  Rheumatol Int       Date:  2010-03-09       Impact factor: 2.631

8.  Possible effect of subclinical inflammation on daily life in familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Fatoş Yalçinkaya; Selçuk Yüksel; Banu Acar; Derya Gökmen; Mesiha Ekim
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

9.  A survey of phenotype II in familial Mediterranean fever.

Authors:  M Melikoğlu; H Ozdoğan; C Korkmaz; O Kasapçopur; N Arisoy; S Akkuş; Z Fresko; H Yazici
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 10.  Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.

Authors:  Seza Ozen; Selcan Demir
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.